Share This Page
Drug Price Trends for AMLODIPINE-BENAZEPRIL
✉ Email this page to a colleague
Average Pharmacy Cost for AMLODIPINE-BENAZEPRIL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| AMLODIPINE-BENAZEPRIL 10-20 MG | 57237-0146-01 | 0.13611 | EACH | 2025-05-21 |
| AMLODIPINE-BENAZEPRIL 10-20 MG | 55111-0341-05 | 0.13611 | EACH | 2025-05-21 |
| AMLODIPINE-BENAZEPRIL 5-40 MG | 68180-0463-01 | 0.15374 | EACH | 2025-05-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Amlodipine-Benazepril
Introduction to Amlodipine-Benazepril
Amlodipine-benazepril, commonly known by the brand name Lotrel, is a combination medication used to treat high blood pressure. It combines an angiotensin-converting enzyme (ACE) inhibitor (benazepril) with a calcium channel blocker (amlodipine). This combination helps to relax blood vessels, making it easier for the heart to pump blood, and thereby reducing blood pressure.
Global Market Size and Growth
The global market for benazepril, which includes amlodipine-benazepril combinations, is projected to experience significant growth. According to Cognitive Market Research, the global benazepril market size is estimated to be USD 102,514.2 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031, reaching USD 149,125.2 million by 2031[1].
Regional Market Breakdown
The market for amlodipine-benazepril is distributed across various regions, each with its own growth prospects:
- North America: This region holds the largest market share, with a market size of USD 57,562.4 million in 2024. It is expected to grow at a CAGR of 3.7% from 2024 to 2031. The United States is the dominant market within North America, with a market size of USD 32,353.5 million in 2024 and a CAGR of 3.5% during the forecast period[1].
- Europe: Europe accounts for more than 30% of the global revenue, with a market size of USD 30,754.26 million in 2024. It is projected to grow at a CAGR of 4.0% from 2024 to 2031[1].
- Asia Pacific: This region holds around 23% of the global revenue, with a market size of USD 23,578.27 million in 2024. It is expected to grow at a CAGR of 7.5% from 2024 to 2031, making it one of the fastest-growing regions[1].
- Latin America and Middle East & Africa: These regions also contribute to the market, with Latin America holding around 5% and the Middle East & Africa holding around 2% of the global revenue. They are expected to grow at CAGRs of 4.9% and 5.2%, respectively, from 2024 to 2031[1].
Growth Drivers
Several factors are driving the growth of the amlodipine-benazepril market:
- Rising Incidences of Cardiovascular Diseases: The increasing prevalence of hypertension, heart failure, and chronic kidney diseases is a major driver. According to the World Health Organization, hypertension affects over 1.28 billion people worldwide, making it a significant risk factor for cardiovascular disorders[1][3].
- Growing Healthcare Expenditure: Improved healthcare infrastructure and increased awareness of cardiovascular health are contributing to the market growth. The availability of cheaper generic formulations of benazepril also enhances market accessibility, especially in emerging economies[3].
- Optimization of Drug Delivery: Research and development in drug delivery systems and combination therapies are further driving the market. For instance, the development of fixed-dose combination (FDC) formulations that include benazepril can simplify treatment regimens and improve patient compliance[3].
Price Projections
The prices of amlodipine-benazepril vary based on the dosage and the pharmacy.
- Generic Versions: The cost for a generic amlodipine-benazepril (10 mg-20 mg) oral capsule can range from $26.58 to $37.31 for a supply of 90 capsules, depending on the pharmacy and any discounts applied[2][5].
- Brand Name (Lotrel): The brand name version, Lotrel, is significantly more expensive. For example, a supply of 100 capsules of Lotrel (5 mg-10 mg) can cost around $1,277.24, and for the 10 mg-20 mg dosage, it can cost around $1,564.89[5].
Market Opportunities
Several opportunities are emerging in the amlodipine-benazepril market:
- Expansion of Generic Market: The expiry of patents for branded versions of benazepril has opened up significant opportunities for generic formulations. Generic versions are more affordable, making them accessible to a broader population, especially in emerging economies[3].
- Combination Therapy Development: There is a growing demand for combination therapies that include benazepril along with other antihypertensive agents. These FDC formulations can simplify treatment regimens and improve patient compliance[3].
- Growing Needs in Emerging Markets: Emerging markets in Asia-Pacific, Latin America, and Africa are experiencing a high rate of hypertension and chronic kidney disease. Improving access to essential medicines in these regions presents a significant opportunity for market growth[3].
Challenges and Constraints
While the market for amlodipine-benazepril is growing, there are some challenges to consider:
- Potential Side Effects and Drug Interactions: Like any medication, amlodipine-benazepril can have side effects and interact with other drugs, which may limit its use in certain patients[2].
- Availability of Better Therapeutic Alternatives: The market may face competition from newer, more effective antihypertensive medications, which could impact the demand for amlodipine-benazepril[3].
Key Takeaways
- The global benazepril market, including amlodipine-benazepril combinations, is expected to grow significantly, driven by the increasing prevalence of hypertension and other cardiovascular diseases.
- Regional markets, particularly in North America, Europe, and Asia Pacific, are key contributors to the global market.
- Generic versions of amlodipine-benazepril are becoming increasingly important due to their affordability and accessibility.
- Combination therapies and emerging markets present significant growth opportunities.
FAQs
Q: What is the projected global market size for benazepril by 2031? A: The global benazepril market size is expected to reach USD 149,125.2 million by 2031[1].
Q: What is the primary driver of the amlodipine-benazepril market? A: The primary driver is the increasing prevalence of hypertension and other cardiovascular diseases[1][3].
Q: How much does a generic amlodipine-benazepril (10 mg-20 mg) oral capsule cost? A: The cost can range from $26.58 to $37.31 for a supply of 90 capsules, depending on the pharmacy and discounts[2][5].
Q: What are the key regions contributing to the amlodipine-benazepril market? A: North America, Europe, and Asia Pacific are the major contributing regions[1].
Q: What opportunities are emerging in the amlodipine-benazepril market? A: The expansion of the generic market, combination therapy development, and growing needs in emerging markets are significant opportunities[3].
Sources
- Cognitive Market Research: Global Benazepril Market Report 2024.
- Drugs.com: Amlodipine/benazepril Prices, Coupons, Copay Cards & Patient Assistance.
- The Insight Partners: Benazepril Market Strategies and Share 2031.
- OpenPR: Amlodipine Besilate Market Size, Share, Development by 2025.
- Drugs.com: Lotrel Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓
